Samsung Bioepis Goes After Lucentis With 40% Cheaper Byooviz Launch In US
Delivers Global First With Ranibizumab Biosimilar Launch Through Partner Biogen
• By David Wallace
The first ophthalmic biosimilar offers significant savings over Lucentis • Source: Shutterstock 
